We invest in exceptional people whose mission in life is to create a better world for our generation and the next ones.
We invest across the engineering biology innovation loop at the earliest stages of company building, primarily Seed and Series A. Since 1969, we have partnered with scores of legendary entrepreneurs and know that company building is a marathon, not a sprint. Learn more about our promise to entrepreneurs.
We have served as early investors to iconic biotech and healthIT entrepreneurs for over 50 years including Amgen, Genentech, Heartstream, Intuitive Surgical, Millennium Pharmaceuticals and Mammoth Biosciences. The ability to marry the engineering approaches of information technology with advances in biology will re-invent trillion dollar industries and transform human and planetary health.
Reversing climate change and preserving humanity is the greatest task of our generation, and also presents the greatest entrepreneurial opportunity in history. By using biology as a technology to reinvent production of the food we eat, the clothes we wear and the places we live and work in, we have a path to zero carbon footprint societies.
POV
Sort By:
Viewpoint | Aug 29 2023
Founding Voices: Dream Boldly, and Move with Purpose
Human & Planetary Health | Founding Voices
Viewpoint | Jun 30 2023
CRISPR+: The Next Generation CRISPR Systems and Applications ...
Human & Planetary Health
Video | Jun 30 2023
Built to Last – Where Will the Next ...
Human & Planetary Health | Company Building
Viewpoint | Dec 5 2022
Saving the World: The Playbook for Building Planetary ...
Human & Planetary Health
Article | Oct 4 2022
Bristol Myers Inks Protein Degrader Deal via Celgene ...
Human & Planetary Health | News
Viewpoint | Oct 4 2022
SyntheX and BMS Partner on Drug Development Deal ...
Human & Planetary Health | News
Entrepreneur Journey | Oct 1 2022
Saving Billions of Lives with Next Generation CRISPR ...
Human & Planetary Health
Viewpoint | Sep 26 2022
Enabling the Next Generation of CRISPR Products
Human & Planetary Health | News
News | Sep 21 2022
Cultured Meat Startup Prolific Machines Unveils its ‘Henry ...
Human & Planetary Health
Viewpoint | Sep 14 2022
Founding Voices: Why a Shared Vision is Essential
Human & Planetary Health | Founding Voices
Video | Jun 7 2022
Scientist Entrepreneurs — The Hard Truths of Scaling ...
Human & Planetary Health
Article | Jun 2 2022
Precision Immunology Platform Endpoint Health Raises $52M Series ...
Human & Planetary Health
Article | May 9 2022
Evolving from Scientist to Founder | TechCrunch Early ...
Human & Planetary Health | Company Building
News | Jan 10 2022
Bayer and Mammoth Biosciences to Collaborate on Novel ...
Human & Planetary Health
Viewpoint | Nov 16 2021
Healthcare Pioneers Share Secrets to Building Iconic Engineering ...
Conscious Capital | Human & Planetary Health
Viewpoint | Oct 4 2021
GraphWear: Solving a Holy Grail Problem to Save ...
Human & Planetary Health | News
News | Sep 9 2021
Mammoth Biosciences Achieves Unicorn Status with $195M Funding
Human & Planetary Health
Entrepreneur Journey | Sep 9 2021
Saving Billions of Lives with Next Generation CRISPR ...
Human & Planetary Health
Article | Aug 19 2021
Discover all things biotech with Mayfield at Disrupt ...
Human & Planetary Health
Podcast | Aug 2 2021
Synthetic Biology & The Biotech Revolution | BIOS
Conscious Capital | Human & Planetary Health
Video | Aug 2 2021
MedTech Insights with Salvatore Viscomi MD & Ursheet ...
Human & Planetary Health
Video | Jun 18 2021
5 Essential Moments in Building a Company
Human & Planetary Health | Company Building
Podcast | May 24 2021
Arvind Shares his Perspective on the SynBio Revolution
Conscious Capital | Human & Planetary Health
Article | Apr 27 2021
Mirvie Wants to Bring Liquid Biopsy Tech to ...
Human & Planetary Health | News
Video | Apr 26 2021
Scientist Entrepreneurs – Scaling Breakout Engineering Biology Companies
Human & Planetary Health
Video | Oct 23 2020
Ursheet Shares Engineering Biology Investment Trends at SynBioBeta ...
Human & Planetary Health
Video | Oct 22 2020
Ursheet Shares his Perspective on Neuromodulation at SynBioBeta ...
Human & Planetary Health
Article | Oct 7 2020
Jennifer Doudna Wins Nobel Prize for CRISPR Discovery
Human & Planetary Health | News
Podcast | Aug 27 2020
Funding Biology with Conscious Capital to Save the ...
Conscious Capital | Human & Planetary Health
Viewpoint | Jul 15 2020
Investing in Human and Planetary Evolution
Conscious Capital | Human & Planetary Health | News
Viewpoint | Jul 13 2020
Endpoint Health: Partnering with Founders Building the Precision ...
Human & Planetary Health | News
Viewpoint | Jun 22 2020
Three Post-Pandemic Areas of Opportunity in Digital Health ...
Human & Planetary Health
Viewpoint | Jun 10 2020
Engineering Biology Company Building
Human & Planetary Health | Company Building
Article | Jun 5 2020
Jennifer Doudna Shares How COVID-19 is Spurring Science ...
Human & Planetary Health
Article | May 13 2020
The New Diagnostics Marketplace in a Post-COVID-19 World
Human & Planetary Health
Article | Apr 9 2020
Investing in Times of Turmoil, Neurotech and Happiness
Human & Planetary Health
Viewpoint | Apr 5 2020
Innovators Accelerating Delivery of COVID-19 Solutions
Human & Planetary Health
Article | Mar 13 2020
Qventus Offers a Solution for Hospitals to Predict ...
Human & Planetary Health
Viewpoint | Jan 30 2020
Enabling the Next Generation of CRISPR Products
Human & Planetary Health | News
Article | Dec 2 2019
Digitizing Biology and Scaling Precision Medicine Companies
Human & Planetary Health
Viewpoint | Sep 24 2019
Biology as Technology Will Reinvent Trillion Dollar Industries
Human & Planetary Health
Viewpoint | Jul 29 2019
Shaping the Future with Mission Bio’s Internship Program
Human & Planetary Health | Company Building
Viewpoint | Jul 15 2019
Key Takeaways & Predictions from Health Evolution Summit ...
Human & Planetary Health
Article | Mar 5 2019
The Four Key Elements to Scaling Health IT ...
Human & Planetary Health | Company Building
Video | Jan 20 2019
Mammoth Biosciences CEO Trevor Martin & Ursheet Parikh ...
Human & Planetary Health
Article | Dec 13 2018
Mission Bio Raises $30 Million in Series B ...
News | Human & Planetary Health
Viewpoint | Oct 3 2018
Building Synthetic Biology Companies at Scale
Human & Planetary Health | Company Building
Article | Sep 20 2018
Bio-Platforms: The Future of Innovation and Collaboration
Human & Planetary Health
Article | Jul 31 2018
Mammoth Biosciences Raises $23 Million for its CRISPR-based ...
Human & Planetary Health | News
Viewpoint | Jul 31 2018
CRISPR and the Precision Medicine Revolution
Human & Planetary Health | News
Viewpoint | Jun 19 2018
Healthcare Takes Center Stage At Mayfield Reception
Human & Planetary Health
Viewpoint | Dec 14 2017
Navin Chaddha on the Journey with Brighter
Human & Planetary Health | News | Enterprise
Viewpoint | Oct 12 2017
Mission Bio Delivers on the Promise of Precision ...
Human & Planetary Health | News
Viewpoint | Sep 18 2017
Ursheet Parikh Hosts Discussion on Digital Health Trends
Human & Planetary Health
Article | Jul 26 2017
A People-First View of Investing in Innovation
Enterprise | Consumer | Human & Planetary Health
Entrepreneur Journey | Mar 20 2017
Three Pivots to Better Healthcare
Human & Planetary Health | Gamechangers
Article | Mar 16 2017
Mayfield’s Parikh on What Makes Digital Health Startups ...
Human & Planetary Health
Investments
Human & Planetary Health Team

Ursheet Parikh
Read Bio

Ursheet Parikh
Ursheet invests in Infrastructure Software and Human & Planetary Health.
His investments in the enterprise sector include Versa Networks (Security and SD-WAN), Qwiet (Application Security), Rancher Labs (Cloud Computing platform acquired by SUSE), CloudGenix (SD-WAN platform acquired by Palo Alto Networks) and Netsil (Application Observability platform acquired by Nutanix).
Ursheet’s investments in human & planetary health include Mammoth Biosciences (CRISPR), Mission Bio (Single Cell Sequencing, Oncology), Qventus (Healthcare AI), Endpoint Health (Precision Immunology), Mirvie (predict and prevent pregnancy complications for moms and babies), GraphWear (Continuous Non-invasive Glucose Monitoring), Chemix (AI-powered next gen EV battery technologies) and Foodsmart (reverse metabolic disease).
Prior to Mayfield, Ursheet had an operating career as a repeat entrepreneur and executive at Cisco and Microsoft. Ursheet was co-founder & CEO of StorSimple – the leading cloud-integrated storage company that was acquired by Microsoft in 2012.
Ursheet holds an MBA from the Wharton School and a Bachelors in Computer Science from the Indian Institute of Technology in Mumbai, from which he received the Young Alumni Achiever award in 2015.
Ursheet is passionate about accelerating healthcare innovation and transforming college education where his family foundation is focused.
Full Bio
Arvind Gupta
Read Bio

Arvind Gupta
Arvind Gupta focuses on investments in Human & Planetary Health where his mission is to invest in science based companies that could change history. Ranging from reinventing our food system to stopping climate change to novel therapeutics, Arvind was the first investor in breakout companies such as Geltor,Synthex, Prime Roots, NotCo, Prellis, New Culture, DNA Lite, Catalog, Prellis and Memphis Meats.
As Founder of IndieBio, Arvind redefined the pace and possibilities of early stage biotech, investing in over 136 companies in five years, defining human and planetary health, and growing the IndieBio portfolio into billions of dollars in value. Under his leadership, IndieBio expanded to New York and grew to fifteen investment professionals with a world renowned adjunct partner board. He now serves as Venture Advisor at IndieBio.
Arvind is the author of Decoding the World: A Roadmap for the Questioner, published by Twelve Books, a division of the Hachette Publishing Group. He was honored with the F50 Global Award for Impact in HealthTech Innovation. He is a frequent speaker at TechCrunch Disrupt, Slush, TedX and Future FoodTech. His work has been profiled in global media outlets such as Bloomberg News, Forbes, The Guardian UK, Neo.life, Nikkei News, Rotman, The Times of India, and CGTN in China. Arvind has been a guest lecturer at UCSF, MIT and Harvard and is a judge at the annual BIO conference startup stadium.
Prior to founding IndieBio, Arvind was Design Director at IDEO in Shanghai where he earned numerous international design awards and presented his work at the San Francisco Museum of Modern Art. He was also a BASE jumper and big wall climber and now fights professional grappling.
Arvind received his B.S. in Genetic Engineering from UCSB. He holds 8 patents.
Arvind is married to an Icelander and has two daughters.
Full Bio